Kathleen A. Gallo

4.3k total citations · 1 hit paper
71 papers, 3.3k citations indexed

About

Kathleen A. Gallo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kathleen A. Gallo has authored 71 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Kathleen A. Gallo's work include Melanoma and MAPK Pathways (24 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and DNA and Nucleic Acid Chemistry (6 papers). Kathleen A. Gallo is often cited by papers focused on Melanoma and MAPK Pathways (24 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and DNA and Nucleic Acid Chemistry (6 papers). Kathleen A. Gallo collaborates with scholars based in United States, Germany and Poland. Kathleen A. Gallo's co-authors include Gary L. Johnson, Jeremy R. Knowles, Matthew J. Farrer, Julie P. Taylor, Ignácio F. Mata, William J. Wedemeyer, Paul J. Godowski, Robert Preißner, Martin E. Tanner and Andrean Goede and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Kathleen A. Gallo

70 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SuperPred 3.0: drug classification and target prediction—a machine learning approach

2022 148 citations Kathleen A. Gallo, Andrean Goede et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen A. Gallo United States	30	2.2k	450	411	395	324	71	3.3k
Andrea Rasola Italy	40	4.2k 1.9×	503 1.1×	460 1.1×	198 0.5×	496 1.5×	86	5.7k
Anna Maria Brunati Italy	40	3.0k 1.3×	630 1.4×	469 1.1×	134 0.3×	205 0.6×	145	4.8k
Solange Desagher France	18	4.0k 1.8×	540 1.2×	672 1.6×	128 0.3×	377 1.2×	23	5.1k
Hideki Sakahira Japan	18	4.6k 2.1×	497 1.1×	757 1.8×	166 0.4×	584 1.8×	21	5.7k
David L. Selwood United Kingdom	32	1.9k 0.8×	175 0.4×	373 0.9×	87 0.2×	406 1.3×	100	3.7k
Tohru Kamata Japan	31	2.7k 1.2×	464 1.0×	881 2.1×	172 0.4×	257 0.8×	74	4.6k
Mauro Salvi Italy	31	2.3k 1.0×	292 0.6×	392 1.0×	86 0.2×	206 0.6×	94	3.1k
Ana Maria Ibrado United States	9	3.6k 1.6×	293 0.7×	706 1.7×	98 0.2×	313 1.0×	11	4.7k
Evripidis Gavathiotis United States	38	4.5k 2.0×	485 1.1×	780 1.9×	137 0.3×	206 0.6×	75	5.8k
Sylvie Montessuit Switzerland	27	5.9k 2.7×	599 1.3×	691 1.7×	116 0.3×	436 1.3×	38	7.0k

Countries citing papers authored by Kathleen A. Gallo

Since Specialization

Citations

This map shows the geographic impact of Kathleen A. Gallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen A. Gallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen A. Gallo more than expected).

Fields of papers citing papers by Kathleen A. Gallo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen A. Gallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen A. Gallo. The network helps show where Kathleen A. Gallo may publish in the future.

Co-authorship network of co-authors of Kathleen A. Gallo

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen A. Gallo. A scholar is included among the top collaborators of Kathleen A. Gallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen A. Gallo. Kathleen A. Gallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kemmler, Emanuel, Marie Chantal Lemfack, Andrean Goede, et al.. (2024). mVOC 4.0: a database of microbial volatiles. Nucleic Acids Research. 53(D1). D1692–D1696. 15 indexed citations

Gallo, Kathleen A., et al.. (2023). Withdrawn 2.0—update on withdrawn drugs with pharmacovigilance data. Nucleic Acids Research. 52(D1). D1503–D1507. 2 indexed citations

Misek, Sean A., Thomas S. Dexheimer, Susan E. Conrad, et al.. (2022). BRAF Inhibitor Resistance Confers Increased Sensitivity to Mitotic Inhibitors. Frontiers in Oncology. 12. 766794–766794. 4 indexed citations

Appleton, Kathryn M., Charuta C. Palsuledesai, Sean A. Misek, et al.. (2021). Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in NRAS-Mutant Melanoma Cell Lines. Cancers. 13(9). 2012–2012. 8 indexed citations

Gallo, Kathleen A., et al.. (2021). Prediction of oral squamous cell carcinoma based on machine learning of breath samples: a prospective controlled study. BMC Oral Health. 21(1). 500–500. 14 indexed citations

Erfinanda, Lasti, Krishnan Ravindran, Kathleen A. Gallo, et al.. (2020). Oestrogen-mediated upregulation of the Mas receptor contributes to sex differences in acute lung injury and lung vascular barrier regulation. European Respiratory Journal. 57(1). 2000921–2000921. 40 indexed citations

Misek, Sean A., Thomas S. Dexheimer, Erika M. Lisabeth, et al.. (2019). Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells. Oncogene. 39(7). 1466–1483. 42 indexed citations

Gallo, Kathleen A., et al.. (2019). Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation. Pharmacology & Therapeutics. 207. 107457–107457. 17 indexed citations

Misek, Sean A., et al.. (2017). EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion. Molecular Cancer Research. 15(8). 1085–1095. 27 indexed citations

10.

Conrad, Susan E., et al.. (2017). MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells. Oncogenesis. 6(6). e345–e345. 51 indexed citations

11.

Tamkus, Deimante, Alla Sikorskii, Kathleen A. Gallo, et al.. (2013). Endothelin-1 Enriched Tumor Phenotype Predicts Breast Cancer Recurrence. ISRN Oncology. 2013. 1–7. 10 indexed citations

12.

Chen, Jian & Kathleen A. Gallo. (2012). MLK3 Regulates Paxillin Phosphorylation in Chemokine-Mediated Breast Cancer Cell Migration and Invasion to Drive Metastasis. Cancer Research. 72(16). 4130–4140. 77 indexed citations

13.

Liou, Geou‐Yarh, et al.. (2010). Induced, selective proteolysis of MLK3 negatively regulates MLK3/JNK signalling. Biochemical Journal. 427(3). 435–443. 6 indexed citations

14.

Gallo, Kathleen A., et al.. (2010). MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells. Oncogene. 29(31). 4399–4411. 61 indexed citations

15.

Liou, Geou‐Yarh & Kathleen A. Gallo. (2009). New biochemical approaches towards understanding the Parkinson's disease-associated kinase, LRRK2. Biochemical Journal. 424(1). e1–e3. 4 indexed citations

16.

Zhang, Hua & Kathleen A. Gallo. (2001). Autoinhibition of Mixed Lineage Kinase 3 through Its Src Homology 3 Domain. Journal of Biological Chemistry. 276(49). 45598–45603. 62 indexed citations

17.

Vacratsis, Panayiotis O. & Kathleen A. Gallo. (2000). Zipper-mediated Oligomerization of the Mixed Lineage Kinase SPRK/MLK-3 Is Not Required for Its Activation by the GTPase cdc 42 but Is Necessary for Its Activation of the JNK Pathway. Journal of Biological Chemistry. 275(36). 27893–27900. 46 indexed citations

18.

Gallo, Kathleen A., et al.. (1996). Research Presentations: Disseminating Knowledge for Practice. Journal of the American Academy of Nurse Practitioners. 8(6). 277–281. 3 indexed citations

19.

LUDEMAN, S. M., Victoria L. Boyd, Judith B. Regan, et al.. (1986). ChemInform Abstract: Synthesis and Antitumor Activity of Cyclophosphamide Analogues.. Chemischer Informationsdienst. 17(38). 10 indexed citations

20.

Gallo, Kathleen A., et al.. (1978). Factors Influencing Migrant High School Students to Drop Out or Graduate from High School.. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact